Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Sep:22:680-684.
doi: 10.1016/j.jgar.2020.06.016. Epub 2020 Jul 1.

Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going

Luis Gabriel Parra-Lara  1 , Juan José Martínez-Arboleda  2 , Fernando Rosso  3
Affiliations
Comment

Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going

Luis Gabriel Parra-Lara et al. J Glob Antimicrob Resist. 2020 Sep.

Abstract

  1. •

    Azithromycin (AZM) is a promising drug candidate for the treatment of the COVID-19.

  2. •

    Studies so far on the use of AZM in COVID-19 patients have various methodological limitations.

  3. •

    The evidence on the efficacy of AZM as an adjunct to hydroxychloroquine for COVID-19 is not enough yet.

  4. •

    Combination of AZM and HCQ should be decided with caution due serious cardiac adverse effects.

  5. •

    Currently, 21 clinical trials are being carried out on the use of AZM in COVID-19.

Keywords: Azithromycin; COVID-19; Clinical trial; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2.

PubMed Disclaimer

Comment on

References

    1. Sargiacomo C., Sotgia F., Lisanti M.P. COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection? Aging (Albany NY) 2020;12:6511–6517. doi: 10.18632/aging.103001. - DOI - PMC - PubMed
    1. Kagkelaris K.A., Makri O.E., Georgakopoulos C.D., Panayiotakopoulos G.D. An eye for azithromycin: review of the literature. Ther Adv Ophthalmol. 2018;10 doi: 10.1177/2515841418783622. - DOI - PMC - PubMed
    1. Banjanac M., Munić Kos V., Nujić K., Vrančić M., Belamarić D., Crnković S. Anti-inflammatory mechanism of action of azithromycin in LPS-stimulated J774A.1 cells. Pharmacol Res. 2012;66:357–362. doi: 10.1016/j.phrs.2012.06.011. - DOI - PubMed
    1. Gielen V., Johnston S.L., Edwards M.R. Azithromycin induces anti-viral responses in bronchial epithelial cells. Eur Respir J. 2010;36:646–654. doi: 10.1183/09031936.00095809. - DOI - PubMed
    1. Gautret P., Lagier J.-C., Parola P., Hoang V.T., Meddeb L., Mailhe M. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;(March) doi: 10.1016/j.ijantimicag.2020.105949. [Epub ahead of print] - DOI - PMC - PubMed